Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 29, 2021 4:00 P.M.
Form: S-3
CIK: 0001701108
Company Name: Spero Therapeutics, Inc.
File Number: 333-254170